$BBIO announced that the #FDA approved Attruby (acoramidis) for the treatment of adults with ATTR-CM to reduce #cardiovascular death and cardiovascular-related hospitalization.
#biotech
www.biopharmcatalyst.com/company/BBIO...

$BBIO Approved! $XBI

Waiting for opportunity to get back into $ATRA. $XBI needs to show bottom first.